NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
Awarded by NHS England · 2024-08-02T15:50:25+01:00 · £1,100,000,000
Description
NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin Offer reference number: CM/PHS/23/5703 The period of the framework is 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months. …
- Buyer
- NHS England
- Value
- £1,100,000,000
- Category (CPV)
- Immunoglobulins
- Award date
- 2024-08-02T15:50:25+01:00
- Buyer constituency
- runcorn-and-helsby
Full CPV hierarchy, related awards from the same supplier and buyer, and any declared MP interest overlaps load below when JavaScript is enabled.